Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-004204
Filing Date
2023-03-20
Accepted
2023-03-20 17:00:42
Documents
53

Document Format Files

Seq Description Document Type Size
1 DEF 14A abbv-20230505xdef14a.htm   iXBRL DEF 14A 3361598
2 GRAPHIC abbv-20230505xdef14a_a001.jpg GRAPHIC 9212
3 GRAPHIC abbv-20230505xdef14a_a002.jpg GRAPHIC 2919
4 GRAPHIC abbv-20230505xdef14a_a003.jpg GRAPHIC 3072
5 GRAPHIC abbv-20230505xdef14a_a004.jpg GRAPHIC 1946
6 GRAPHIC abbv-20230505xdef14a_a005.jpg GRAPHIC 3593
7 GRAPHIC abbv-20230505xdef14a_a006.jpg GRAPHIC 3949
8 GRAPHIC abbv-20230505xdef14a_a007.jpg GRAPHIC 4403
9 GRAPHIC abbv-20230505xdef14a_a008.jpg GRAPHIC 2964
10 GRAPHIC abbv-20230505xdef14a_a009.jpg GRAPHIC 7934
11 GRAPHIC abbv-20230505xdef14a_a012.jpg GRAPHIC 2168
12 GRAPHIC abbv-20230505xdef14a_a013.jpg GRAPHIC 1715
13 GRAPHIC abbv-20230505xdef14a_a014.jpg GRAPHIC 1735
14 GRAPHIC abbv-20230505xdef14a_a018.jpg GRAPHIC 2184
15 GRAPHIC abbv-20230505xdef14a_a019.jpg GRAPHIC 4775
16 GRAPHIC abbv-20230505xdef14a_a020.jpg GRAPHIC 4910
17 GRAPHIC abbv-20230505xdef14a_a021.jpg GRAPHIC 5132
18 GRAPHIC abbv-20230505xdef14a_a022.jpg GRAPHIC 25257
19 GRAPHIC abbv-20230505xdef14a_a023.jpg GRAPHIC 24037
20 GRAPHIC abbv-20230505xdef14a_a024.jpg GRAPHIC 12339
21 GRAPHIC abbv-20230505xdef14a_a027.jpg GRAPHIC 7387
22 GRAPHIC abbv-20230505xdef14a_a028.jpg GRAPHIC 4455
23 GRAPHIC abbv-20230505xdef14a_a029.jpg GRAPHIC 6108
24 GRAPHIC abbv-20230505xdef14a_a030.jpg GRAPHIC 6558
25 GRAPHIC abbv-20230505xdef14a_a031.jpg GRAPHIC 4955
26 GRAPHIC abbv-20230505xdef14a_a032.jpg GRAPHIC 4645
27 GRAPHIC abbv-20230505xdef14a_a033.jpg GRAPHIC 6395
28 GRAPHIC abbv-20230505xdef14a_a034.jpg GRAPHIC 6705
29 GRAPHIC abbv-20230505xdef14a_a035.jpg GRAPHIC 7031
30 GRAPHIC abbv-20230505xdef14a_a036.jpg GRAPHIC 8150
31 GRAPHIC abbv-20230505xdef14a_a037.jpg GRAPHIC 7168
32 GRAPHIC abbv-20230505xdef14a_a052.jpg GRAPHIC 61060
33 GRAPHIC abbv-20230505xdef14a_a054.jpg GRAPHIC 61241
34 GRAPHIC abbv-20230505xdef14a_a063.jpg GRAPHIC 40884
35 GRAPHIC abbv-20230505xdef14a_a064.jpg GRAPHIC 43680
36 GRAPHIC abbv-20230505xdef14a_a071.jpg GRAPHIC 4477
37 GRAPHIC abbv-20230505xdef14a_bg001.jpg GRAPHIC 134717
38 GRAPHIC abbv-20230505xdef14a_bg002.jpg GRAPHIC 101529
39 GRAPHIC abbv-20230505xdef14a_bg003.jpg GRAPHIC 139348
40 GRAPHIC abbv-20230505xdef14a_bg004.jpg GRAPHIC 115080
  Complete submission text file 0001558370-23-004204.txt   7197255

Data Files

Seq Description Document Type Size
41 EX-101.SCH abbv-20230505.xsd EX-101.SCH 7386
42 EX-101.DEF abbv-20230505_def.xml EX-101.DEF 10375
43 EX-101.LAB abbv-20230505_lab.xml EX-101.LAB 18515
44 EX-101.PRE abbv-20230505_pre.xml EX-101.PRE 8813
47 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20230505xdef14a_htm.xml XML 565794
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35565 | Film No.: 23747021
SIC: 2834 Pharmaceutical Preparations